GLOW
$89.99
A triple-peptide combination of BPC-157, TB-500, and GHK-Cu targeting complementary angiogenic, cellular migration, and extracellular matrix remodeling pathways in preclinical research. Premium Research Peptide.
1000 in stock
🔥 Exclusive Crypto Offer
Get an INSTANT 15% DISCOUNT when you pay with Bitcoin, Ethereum, Dogecoin, Bitcoin Cash, XRP, Solana, or USDT.
⚡ Don't have crypto? Buy it here in 5 minutes with easy guidance.
💡 Pro Tip: You can also pay with cryptocurrency using your verified Cash App or PayPal account for a fast and secure checkout!
Certificate of Analysis
Third Party Tested • ISO/IEC 17025 Accredited • Premium Quality
Purity: 99.77% (✓ Passed Full QC Panel)
GLOW 70mg Specification
| Variant | GLOW 70mg |
| Lot # | GLW0001 |
| Labeled | 70mg |
| Actual | 73.27mg |
| GHK-Cu | 52.75mg |
| BPC-157 | 10.40mgTB-410.11mg |
| Tested | May 29, 2026 |
| Full QC Panel | 7× tested |
| Purity (HPLC) | 99.77% |
| Net Peptide Content | 73.27mg |
| Identity (HPLC) | |
| GHK-Cu | + |
| BPC-157 | + TB-4 |
| HPLC Conformity | mean 99.77% |
| Heavy Metals (ICP-MS) | Not Detected |
| Sterility (PCR) | No Growth |
| Endotoxin (USP <85>) | < 0.05 EU/mLISO/IEC 17025 Accredited |
Frequently Researched Together
Dermal research compounds
Component Profiles
What Is In GLOW?
| BPC-157 | 15 amino acids, 1,419 Da |
| TB-500 | 43 amino acids, 4,963 Da |
| GHK-Cu | 3 amino acids + Cu²⁺, 403 DaTotal peptides3 distinct compoundsMechanismsComplementary pathways |
| PubChem Database | s |
Storage Requirements
Stability Information
Research Status
Where Each Stands
| BPC-157 | : Preclinical |
| TB-500 | : Preclinical |
| GHK-Cu | : Cosmetic + Research |
| BPC-157 | studies200+ publications |
| TB-500 | studies170+ publications |
| GHK-Cu | studies130+ publicationsCombination studiesEmerging researchPubMed Search |
Related products
Cellular Peptide Blend
Cellular Peptide Blend